| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af382ed9261ff2e48c93b51164a8084c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3af602b52a119836091e5ad90cf61bd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4ebd38652ac65c9127cdaef1779db3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2005-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a93b731460d2786a7685b2e45fd5aace
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e6139173fd785abb67c76e695f52a98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f79f128636ad733aaf23a46b412a89ce |
| publicationDate |
2008-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008287467-A1 |
| titleOfInvention |
Therapeutic Agent for Respiratory Diseases |
| abstract |
The invention provides a therapeutic agent for respiratory diseases, which is based on a new activity mechanism of the antagonism to the P2X4 receptor and by which fewer adverse activities of the existing β-stimulants on the cardiovascular system can be expected. The therapeutic agent of the invention is antagonistic to the P2X4 receptor present in bronchial smooth muscle and is used for the treatment of respiratory diseases caused by bronchocontraction such as asthma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3766497-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11666582-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4001310-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015166105-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015254558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3137501-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10654926-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9555013-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111902146-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011201691-A1 |
| priorityDate |
2004-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |